Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The New Era of Pulmonary Hypertension: The Dawn of Disease Modification & Therapeutic Modalities.

Journal of cardiovascular development and disease·2026
Same author

Variety of <i>Clostridioides difficile</i> Ribotypes in CDI Patients in Las Vegas, NV.

Germs·2026
Same author

Rhabdomyolysis and Acute Kidney Injury after the New York City Marathon.

Nephron·2026
Same author

Cardiac Screening in Young Athletes: The Role of Diagnostics in Preventing Sudden Cardiac Death and Exploring Clearance Protocols.

Journal of clinical medicine·2026
Same author

Left Ventricular Non-Compaction Cardiomyopathy: The Tragedies & Trabeculations of the Architectural Cardiac Sponge.

Journal of clinical medicine·2026
Same author

Infective Endocarditis and Complications; Surgical Indications and Management: An Integrative Review.

Journal of personalized medicine·2026

Related Experiment Video

Updated: Jul 9, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Sleep Apnea and Cardiovascular Disease: Risks, Mechanisms, Complications, and Management.

Noyan Ramazani1, Sahar Mahani2, Mohamad Mubder3

  • 1Department of Internal Medicine, University of Nevada Las Vegas, Kirk Kerkorian School of Medicine, Las Vegas, NV 89102, USA.

Reviews in Cardiovascular Medicine
|July 8, 2026
PubMed
Summary

Sleep apnea, a common disorder affecting over a billion adults, significantly increases cardiovascular disease risk. Effective treatments, including CPAP and lifestyle changes, are vital for managing sleep apnea and preventing heart complications.

Keywords:
atrial fibrillationcardiovascular diseasecontinuous positive airway pressure therapyheart failureintermittent hypoxiapulmonary hypertensionsleep apneasudden cardiac arrest

More Related Videos

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

Related Experiment Videos

Last Updated: Jul 9, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

Area of Science:

  • Cardiology
  • Pulmonology
  • Sleep Medicine

Background:

  • Sleep apnea, characterized by breathing cessations during sleep, is a prevalent global health issue.
  • Obstructive sleep apnea (OSA) is the most common type, affecting approximately 425 million adults worldwide.
  • Sleep apnea is strongly linked to severe cardiovascular diseases (CVD), including hypertension, heart failure, and stroke.

Purpose of the Study:

  • To review current medical therapies for sleep apnea and its cardiovascular sequelae.
  • To emphasize the importance of early screening and multidisciplinary management.
  • To discuss strategies for reducing mortality in patients with sleep apnea and CVD.

Main Methods:

  • Review of guideline-directed medical therapies for sleep apnea.
  • Discussion of continuous positive airway pressure (CPAP) and pharmacological interventions.
  • Highlighting the STOP-BANG questionnaire for sleep apnea screening.

Main Results:

  • Sleep apnea contributes to major cardiovascular complications through intermittent hypoxia and inflammation.
  • Effective management of sleep apnea is critical for mitigating cardiovascular risks.
  • A multidisciplinary approach is essential for comprehensive patient care.

Conclusions:

  • Institutionally sponsored and guideline-directed therapies can reduce mortality in sleep apnea patients with CVD.
  • Early screening and prompt intervention are crucial for preventing cardiovascular damage.
  • Integrated management strategies are key to improving outcomes for individuals with sleep apnea and associated cardiovascular conditions.